Loading data
AQBNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | 2.47 m USD | 3.14 m USD | 1.17 m USD |
| Research and development expense | — | 203.3 k USD | 506.24 k USD | 903.98 k USD | 2.15 m USD |
| Operating profit | -4.02 m USD | -9.63 m USD | -13.67 m USD | -22.32 m USD | -22.12 m USD |
| Interest expense | — | — | 303.97 k USD | 291.18 k USD | 316.44 k USD |
| Profit before tax | -2.23 m USD | -11.38 m USD | -13.84 m USD | -22.16 m USD | -22.32 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -18.49 m USD | -149.19 m USD | -27.56 m USD | -22.16 m USD | -22.32 m USD |
| Basic earnings per share | -4.77 USD/share | -38.65 USD/share | -7.17 USD/share | -5.78 USD/share | — |
| Diluted earnings per share | -4.77 USD/share | -38.65 USD/share | -7.17 USD/share | -5.78 USD/share | -0.32 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.